Skip to content
Screener

Other geography segments

EMEA
$37.35M+21.9%
APAC
$9.06M+30.1%

Similar metrics at other companies

Lumentum Holdings Inc. logo
LITEAmericas — Revenue
$290.9M+151%
TETRA Technologies logo
TTISouth America — Revenue
$16.4M+16.0%
Fabrinet logo
FNNorth America — Revenue
$633.03M+57.0%
Helios Technologies logo
HLIOAmericas — Revenue
$128.7M+20.7%
Harmonic logo
HLITAmericas — Revenue
$106.43M+41.9%
AECOM logo
ACMAmericas — Revenue
$2.91B+0.5%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$6.84B+338%
Enterprise value$6.83B+370%
P/S16.7×+12.4×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(in thousands)Three months ended March 31, 2026Three months ended March 31, 2025Six months ended March 31, 2026Six months ended March 31, 2025
Americas$64,307$55,189$122,688$108,899
EMEA37,34730,64275,71258,945
APAC9,0616,96216,01313,662
Total$110,715$92,793$214,413$181,506

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's americas — revenue?
Twist Bioscience Corporation (TWST) reported americas — revenue of $64.31M in Q1 2026.
How has Twist Bioscience Corporation's americas — revenue changed year-over-year?
Twist Bioscience Corporation's americas — revenue increased by 16.5% year-over-year, from $55.19M to $64.31M.
What is the long-term trend for Twist Bioscience Corporation's americas — revenue?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's americas — revenue has grown at a 30.4% compound annual growth rate (CAGR), from $77.91M to $225.58M.
What does americas — revenue mean?
This metric represents the total gross revenue generated from sales of synthetic biology products and services within the Americas geographic region. It serves as a key indicator of the company's market penetration and commercial success in its primary domestic and regional markets. Tracking this figure helps investors assess regional demand trends and the effectiveness of local sales and distribution strategies.

Ask your AI about Twist Bioscience Corporation's americas — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude